<think>
Okay, let's tackle this problem. The user wants me to process a Finnish histopathological report on prostate cancer and extract structured data into JSON with three specific fields: Sampletype, Malignancy, and Gleason. The input is a free-text report, and I need to parse it according to the given rules.

First, I need to determine the sample type. The allowed values are "biopsy", "RP", "TURP", or "NA". The example given uses "biopsy" when the text mentions "Prostata biopsiasta". Looking at the current input: "Tutkittavana edustavaa prostatakudosta sovituista paikoista. Näytteiden yhteismäärä on riittävä." The term "prostatakudosta" refers to prostate tissue, but there's no explicit mention of biopsy, RP (radical prostatectomy), or TURP (transurethral resection of the prostate). So the sample type isn't specified here. Therefore, Sampletype should be "NA".

Next, checking for malignancy. The allowed values are "kyllä", "ei", or "NA". The text mentions seeing gland structures (rauhasrakenteita) and some wavy epithelium (aaltoilevaa epiteeliä), but there's no mention of cancer, adenocarcinoma, or malignancy. The conclusion is still pending ("Loppupäätelmä on vielä kesken ja valmistuu lähipäivinä."). Since the report is not finalized and no malignancy is explicitly stated, the Malignancy field should be "NA".

For Gleason score, the format is "major+minor=sum" if malignant, otherwise "NA". Since malignancy isn't confirmed here, Gleason should be "NA".

Putting it all together, the JSON should have all fields as "NA" because the sample type isn't specified, malignancy isn't confirmed, and the report is pending. The example provided for an unclear report also results in all NAs, which matches this scenario.
</think>

```json
{
  "Sampletype": "NA",
  "Malignancy": "NA",
  "Gleason": "NA"
}
``` 

**Rationale:**  
1. **Sampletype**: The text refers to "prostatakudosta" (prostate tissue) but does not explicitly mention biopsy, RP, or TURP. Terms like "näytteet" (samples) are too generic.  
2. **Malignancy**: The report describes benign findings (e.g., "rauhasrakenteita", "aaltoilevaa epiteeliä") and explicitly states that the final conclusion is pending ("Loppupäätelmä on vielä kesken"). No malignancy is confirmed.  
3. **Gleason**: Since no malignancy is reported, Gleason grading is irrelevant. The pending conclusion further supports "NA".